Manipal’s American University of Antigua College of Medicine launches trimester

IMT News Desk
IMT News Desk
· 2 min read

Indian students will have greater flexibility and faster pathways to a medical career

Manipal’s American University of Antigua (AUA) College of Medicine has announced a significant academic shift, offering Indian students greater flexibility and faster pathways to a medical career. Beginning this September, Manipal’s AUA will transition to a trimester schedule, enabling new student intakes three times a year in May, September, and January. 

Manipal’s AUA offers a comprehensive medical programme tailored for students who have completed their 12th grade or equivalent, and aspire to become global doctors, practicing in the US, Canada, or the UK. Students can opt to begin their academic journey at the Manipal Academy of Higher Education (MAHE) in Manipal, India. 

The introduction of the third intake in May, starting this September, means students no longer have to wait for traditional academic cycles This change not only allows them to begin their medical education sooner but also reduces the overall duration of the MD program from 6.5 years to six years. Students can graduate earlier and progress more quickly toward clinical rotations and licensure. With a shorter timeline, students will also incur lower expenses related to housing, travel, and daily living, making medical school more affordable and accessible.

“This new trimester reflects our commitment to meeting students where they are and supporting their academic goals with greater flexibility,” said Dr Peter Bell, President of AUA. “By offering an additional start date, we’re empowering future physicians to take control of their timelines and move forward with confidence.”

The trimester schedule maintains AUA’s rigorous academic standards while enhancing overall efficiency. A key benefit is the integration of the Global Health Track, previously a separate program, into the core curriculum. Offered in collaboration with Florida International University (FIU), this track ensures that all students gain exposure to global health systems, community engagement, and public health challenges.

Depending on their entry point, students may also become eligible to apply for residency programs up to a year ahead of schedule, giving them a competitive edge and accelerating their medical careers.

Read Next

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences
Global News
January 20, 2026

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences

To advance BOT+BAL and strengthen US manufacturing readiness Agenus, a leader in immuno-oncology innovation, announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is designed to accelerate global development and potential commercialisation of Agenus’ botensilimab and balstilimab (BOT+BAL) immunotherapy combination programme. The collaboration provides Agenus with strategic capital and […]
Article by: IMT News Desk
Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia
Global News
January 16, 2026

Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia

Approval marks Venus Remedies’ first anti-infective marketing authorisation in Indonesia and enables the country’s first generic entry for this critical antibiotic combination Venus Remedies has secured the marketing authorisation from the Indonesian regulatory authority for its combination antibiotic, Ceftazidime + Avibactam. This approval represents Venus Remedies’ first marketing authorization in the anti-infective segment in Indonesia […]
Article by: IMT News Desk
Wegovy pill approved in the US for weight management
Global News
December 26, 2025

Wegovy pill approved in the US for weight management

Novo Nordisk expects to launch the Wegovy pill in the US in early January 2026 Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse […]
Article by: IMT News Desk
Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK
Global News
December 24, 2025

Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK

Under the terms of the agreement, with closing anticipated toward the end of Q1 of 2026, Samsung Biologics will acquire the Rockville assets for $280 million Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100 […]
Article by: IMT News Desk